International Flavors & Fragrances Inc

Explore how Carl Icahn’s unwavering stake in International Flavors & Fragrances showcases his long‑term, fundamentals‑driven strategy, balancing volatility with steady demand in the flavor sector.

Discover how IFF’s rising analyst targets, margin gains, and green product launch could reshape its competitive edge, while highlighting commodity and regulatory risks.

PureStrong by IFF offers a single‑strain, dog‑specific probiotic backed by science, poised to capture premium pet‑health spend while navigating regulatory and market challenges.

Explore IFF’s insider trades: CEO buys 12,500 shares, execs boost holdings, RSU conversions boost ESG confidence—signals of strong management alignment and market strategy.

International Flavors & Fragrances expands into Latin America and secures a key health‑claim approval in Australia/New Zealand, boosting its plant‑based, clean‑label portfolio and global reach.

International Flavors & Fragrances’ insider trades reveal regulatory transparency, modest holdings, and a resilient stock amid lower oil prices and sector rebound.

Executive equity transactions at IFF reveal insider confidence amid volatility, highlighting potential buy‑back signals and hidden risks for investors.

IFF expands Latin American enzyme production and innovation, boosting local fermentation in Argentina and creating a Brazil lab for faster, region‑specific solutions in health‑biosciences.

International Flavors & Fragrances launches a new Latin American enzyme hub, boosting regional health‑bioscience innovation, supply chain resilience, and ESG impact.

Discover why IFF’s earnings lag peers and how pivoting to natural, functional ingredients and stronger R&D could unlock value.